FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294168994> ?p ?o ?g. }

• W4294168994 abstract "Abstract Background The limited therapeutic outcomes of atherosclerosis (AS) have allowed, traditional Chinese medicine has been well established as an alternative approach in ameliorating AS and associated clinical syndromes. Clinically, Tongsaimai tablet (TSMT), a commercial Chinese patent medicine approved by CFDA, shows an obvious therapeutic effect on AS treatment. However, its effective mechanism and quality control still need thorough and urgent exploration. Methods The mice were orally administered with TSMT and their serum was investigated for the absorbed compounds using serum pharmacochemistry via the UPLC-Q-Exactive Orbitrap/MS analysis was employed to investigate these absorbed compounds in serum of mice orally administrated with TSMT. Based on these absorbed prototype compounds in serum derived from TSMT, a component-target-disease network was constructed using network pharmacology strategy, which elucidated the potential bioactive components, effective targets, and molecular mechanisms of TSMT against AS. Further, the screened compounds from the component-target network were utilized as the quality control (QC) markers, determining multi-component content determination and HPLC fingerprint to assess quality of nine batches of TSMT samples. Results A total of 164 individual components were identified in TSMT. Among them, 29 prototype compounds were found in serum of mice administrated with TSMT. Based on these candidate prototype components, 34 protein targets and 151 pathways related to AS were predicted, and they might significantly exhibit potential anti-AS mechanisms via synergistic regulations of lipid regulation, shear stress, and anti-inflammation, etc. Five potentially bioactive ingredients in TSMT, including Ferulic acid, Liquiritin, Senkyunolide I, Luteolin and Glycyrrhizic acid in quantity not less than 1.2798, 0.4716, 0.5419, 0.1349, 4.0386 mg/g, respectively, screened from the component-target-pathway network. Thereby, these indicated that these five compounds of TMST which played vital roles in the attenuation of AS could serve as crucial marker compounds for quality control. Conclusions Overall, based on the combination of serum pharmacochemistry and network pharmacology, the present study firstly provided a useful strategy to establish a quality assessment approach for TSMT by screening out the potential anti-AS mechanisms and chemical quality markers. Graphical Abstract" @default.
• W4294168994 created "2022-09-02" @default.
• W4294168994 creator A5006912240 @default.
• W4294168994 creator A5008396609 @default.
• W4294168994 creator A5026117242 @default.
• W4294168994 creator A5032823744 @default.
• W4294168994 creator A5050282309 @default.
• W4294168994 creator A5052304130 @default.
• W4294168994 creator A5057255568 @default.
• W4294168994 creator A5076125169 @default.
• W4294168994 creator A5081781774 @default.
• W4294168994 creator A5089774712 @default.
• W4294168994 date "2022-09-02" @default.
• W4294168994 modified "2023-10-16" @default.
• W4294168994 title "Quality assessment and Q-markers discovery of Tongsaimai tablet by integrating serum pharmacochemistry and network pharmacology for anti-atherosclerosis benefit" @default.
• W4294168994 cites W1556863176 @default.
• W4294168994 cites W1759618160 @default.
• W4294168994 cites W1992880896 @default.
• W4294168994 cites W2020280954 @default.
• W4294168994 cites W2032345138 @default.
• W4294168994 cites W2048154453 @default.
• W4294168994 cites W2084621368 @default.
• W4294168994 cites W2095873931 @default.
• W4294168994 cites W2113934014 @default.
• W4294168994 cites W2133408256 @default.
• W4294168994 cites W2146680702 @default.
• W4294168994 cites W2156968631 @default.
• W4294168994 cites W2193969076 @default.
• W4294168994 cites W2275204317 @default.
• W4294168994 cites W2284785118 @default.
• W4294168994 cites W2291696331 @default.
• W4294168994 cites W2356733523 @default.
• W4294168994 cites W2506308679 @default.
• W4294168994 cites W2509936759 @default.
• W4294168994 cites W2592550256 @default.
• W4294168994 cites W2625820457 @default.
• W4294168994 cites W2688936134 @default.
• W4294168994 cites W2734669480 @default.
• W4294168994 cites W2799281420 @default.
• W4294168994 cites W2806986978 @default.
• W4294168994 cites W2889448403 @default.
• W4294168994 cites W2898998405 @default.
• W4294168994 cites W2913086455 @default.
• W4294168994 cites W2913282700 @default.
• W4294168994 cites W2966654380 @default.
• W4294168994 cites W2994869568 @default.
• W4294168994 cites W3003824833 @default.
• W4294168994 cites W3017235151 @default.
• W4294168994 cites W3019335011 @default.
• W4294168994 cites W3090368863 @default.
• W4294168994 cites W3120389957 @default.
• W4294168994 cites W3123239336 @default.
• W4294168994 cites W3123867937 @default.
• W4294168994 cites W3134637368 @default.
• W4294168994 cites W3149352460 @default.
• W4294168994 cites W3160394097 @default.
• W4294168994 cites W3215952199 @default.
• W4294168994 doi "https://doi.org/10.1186/s13020-022-00658-9" @default.
• W4294168994 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36056398" @default.
• W4294168994 hasPublicationYear "2022" @default.
• W4294168994 type Work @default.
• W4294168994 citedByCount "5" @default.
• W4294168994 countsByYear W42941689942020 @default.
• W4294168994 countsByYear W42941689942023 @default.
• W4294168994 crossrefType "journal-article" @default.
• W4294168994 hasAuthorship W4294168994A5006912240 @default.
• W4294168994 hasAuthorship W4294168994A5008396609 @default.
• W4294168994 hasAuthorship W4294168994A5026117242 @default.
• W4294168994 hasAuthorship W4294168994A5032823744 @default.
• W4294168994 hasAuthorship W4294168994A5050282309 @default.
• W4294168994 hasAuthorship W4294168994A5052304130 @default.
• W4294168994 hasAuthorship W4294168994A5057255568 @default.
• W4294168994 hasAuthorship W4294168994A5076125169 @default.
• W4294168994 hasAuthorship W4294168994A5081781774 @default.
• W4294168994 hasAuthorship W4294168994A5089774712 @default.
• W4294168994 hasBestOaLocation W42941689941 @default.
• W4294168994 hasConcept C142724271 @default.
• W4294168994 hasConcept C185592680 @default.
• W4294168994 hasConcept C188947578 @default.
• W4294168994 hasConcept C204787440 @default.
• W4294168994 hasConcept C2776080593 @default.
• W4294168994 hasConcept C2777335409 @default.
• W4294168994 hasConcept C2778004101 @default.
• W4294168994 hasConcept C2780213334 @default.
• W4294168994 hasConcept C2781263971 @default.
• W4294168994 hasConcept C43617362 @default.
• W4294168994 hasConcept C55493867 @default.
• W4294168994 hasConcept C556039675 @default.
• W4294168994 hasConcept C71924100 @default.
• W4294168994 hasConcept C98274493 @default.
• W4294168994 hasConceptScore W4294168994C142724271 @default.
• W4294168994 hasConceptScore W4294168994C185592680 @default.
• W4294168994 hasConceptScore W4294168994C188947578 @default.
• W4294168994 hasConceptScore W4294168994C204787440 @default.
• W4294168994 hasConceptScore W4294168994C2776080593 @default.
• W4294168994 hasConceptScore W4294168994C2777335409 @default.
• W4294168994 hasConceptScore W4294168994C2778004101 @default.
• W4294168994 hasConceptScore W4294168994C2780213334 @default.
• W4294168994 hasConceptScore W4294168994C2781263971 @default.
• W4294168994 hasConceptScore W4294168994C43617362 @default.

• next